| 8.41 -0.13 (-1.52%) | 08-27 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 9.98 |
1-year : | 10.4 |
| Resists | First : | 8.54 |
Second : | 8.9 |
| Pivot price | 8.45 |
|||
| Supports | First : | 7.96 |
Second : | 6.62 |
| MAs | MA(5) : | 8.45 |
MA(20) : | 8.4 |
| MA(100) : | 8.73 |
MA(250) : | 8.88 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 53.3 |
D(3) : | 52.8 |
| RSI | RSI(14): 47.3 |
|||
| 52-week | High : | 10.76 | Low : | 7.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ JYNT ] has closed above bottom band by 41.2%. Bollinger Bands are 51.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 8.59 - 8.64 | 8.64 - 8.67 |
| Low: | 8.22 - 8.27 | 8.27 - 8.32 |
| Close: | 8.33 - 8.41 | 8.41 - 8.49 |
The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.
Mon, 24 Aug 2026
JYNT | The Joint Corp. Financials - Revenue Breakdown - Quiver Quantitative
Mon, 24 Aug 2026
Joint (JYNT) Session: Records a 0.71% Increase to $8.50 in the Latest Reading; Price Levels - vinanet.vn
Thu, 13 Aug 2026
Joint Corp (JYNT) Q2 2026 Earnings Call Transcript - The Globe and Mail
Sat, 08 Aug 2026
The Joint Corp (NASDAQ: JYNT) Share Price, JYNT Stock News, JYNT Share Price & Updates - Kalkine
Thu, 06 Aug 2026
Joint Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Thu, 06 Aug 2026
The Joint Corp. (NASDAQ: JYNT) boosts Q2 profit and keeps 2026 targets - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 14 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 16.2 (%) |
| Held by Institutions | 69.2 (%) |
| Shares Short | 462 (K) |
| Shares Short P.Month | 471 (K) |
| EPS | 0.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.15 |
| Profit Margin | 6.4 % |
| Operating Margin | 3.2 % |
| Return on Assets (ttm) | 2.3 % |
| Return on Equity (ttm) | 10.6 % |
| Qtrly Rev. Growth | 14.3 % |
| Gross Profit (p.s.) | 3.38 |
| Sales Per Share | 4.14 |
| EBITDA (p.s.) | 0.28 |
| Qtrly Earnings Growth | 652.5 % |
| Operating Cash Flow | 5 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | 60.07 |
| PEG Ratio | 8.8 |
| Price to Book value | 7.25 |
| Price to Sales | 2.03 |
| Price to Cash Flow | 22.06 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|